| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/19/2006 | EP1080726B1 Agents for relieving side effects |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | EP1051177B1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase |
| 04/19/2006 | EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants |
| 04/19/2006 | EP1041987B1 Pharmaceutical oral dosage form comprising a combination of an opioid agonist and naltrexone |
| 04/19/2006 | EP1016408B1 Novel paharmaceutical use of c-c chemokine production inhibitors |
| 04/19/2006 | EP1003479B1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 04/19/2006 | EP0946143B1 A nitroimidazole gel composition |
| 04/19/2006 | EP0930877B1 D-methionine to reduce the toxicity of platinum-containing anti-tumor compounds |
| 04/19/2006 | EP0912608B1 Choline binding proteins for anti-pneumococcal vaccines |
| 04/19/2006 | EP0901474B1 Aryl pyrimidine derivatives |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | EP0873355B1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione |
| 04/19/2006 | EP0789574B1 Use of naked polynucleotides in the manufacture of a medicament for treating tumours |
| 04/19/2006 | CN1761760A Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long Q/T syndrome |
| 04/19/2006 | CN1761759A Optimized expression of HPV 31 L1 in yeast |
| 04/19/2006 | CN1761676A Heteroaryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same |
| 04/19/2006 | CN1761673A Guanidine derivatives and use thereof as neuropeptide FF receptor antagonists |
| 04/19/2006 | CN1761672A Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 04/19/2006 | CN1761671A 4-aminothieno [2,3-d] pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors |
| 04/19/2006 | CN1761670A Novel compounds |
| 04/19/2006 | CN1761669A Preparation of a trans-calanolide ketone intermediate and chiral separation of calanolide alcohols to give racemic calanolide A |
| 04/19/2006 | CN1761668A 7-imino derivatives of camptothecin having antitumor activity |
| 04/19/2006 | CN1761666A Polyhydroxylated pyrrolizidine |
| 04/19/2006 | CN1761665A Antitumor effect potentiator and antitumor agent |
| 04/19/2006 | CN1761664A Immunomodulating heterocyclic compounds |
| 04/19/2006 | CN1761662A Composition for promoting production of type I collagen and/or elastin |
| 04/19/2006 | CN1761661A Pharmaceutical preparations containing arginine amides |
| 04/19/2006 | CN1761657A EP4 receptor antagonists |
| 04/19/2006 | CN1761656A 3-(1-[3-(1,3-benzothiazol-6-yl)propylcarbamoyl]cycloalkyl)propanoic acid derivatives as NEP inhibitors |
| 04/19/2006 | CN1761655A Thiazole derivatives and their use as VAP-1 inhibitors |
| 04/19/2006 | CN1761652A Cathepsin S inhibitors |
| 04/19/2006 | CN1761649A Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2 |
| 04/19/2006 | CN1761645A Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| 04/19/2006 | CN1761487A Dispersible formulation of an anti-inflammatory agent |
| 04/19/2006 | CN1761485A Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 04/19/2006 | CN1761481A Osteogenic composition |
| 04/19/2006 | CN1761479A Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 04/19/2006 | CN1761477A Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 04/19/2006 | CN1761476A Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using roystonea regia (royal palm) fruits |
| 04/19/2006 | CN1761473A Heterobifunctional polymeric bioconjugates |
| 04/19/2006 | CN1761472A Regulation of cell surface proteins |
| 04/19/2006 | CN1761471A Combined use of ribavirin and interferon beta in demyelinating diseases |
| 04/19/2006 | CN1761470A Combination of a macrolide t-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease |
| 04/19/2006 | CN1761469A Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| 04/19/2006 | CN1761468A Novel bicyclic compounds and compositions |
| 04/19/2006 | CN1761467A Use of pyridin-2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin |
| 04/19/2006 | CN1761466A Therapeutic and/or preventive agent for chronic skin disease |
| 04/19/2006 | CN1761465A Method for manufacturing coated formulation |
| 04/19/2006 | CN1761464A Substituted p-diaminobenzene derivatives |
| 04/19/2006 | CN1761463A Method for increasing the oral bioavailability of s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]-2-methylpropanethioate |
| 04/19/2006 | CN1761462A Patch containing nonsteroidal antiinflammatory and analgesic agent |
| 04/19/2006 | CN1761461A Compositions and methods for treatment of premature ejaculation |
| 04/19/2006 | CN1761460A Antiflatulents in combination with histamine H1-receptor antagonists for treating gastrointestinal disorders |
| 04/19/2006 | CN1761459A Blood pressure-lowering agent, vascular flexibility-improving agent and foods having these functions imparted thereto |
| 04/19/2006 | CN1761454A Method for preparing small particles |
| 04/19/2006 | CN1761452A Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 04/19/2006 | CN1761450A Skin preparation for external use characterized by containing sugar derivative of a,a-trehalose |
| 04/19/2006 | CN1761406A Comestibles containing isomaltulose and trehalose for sustained carbohydrate energy release and reduced glycemic/insulinemic responses, and for preserving osmolality |
| 04/19/2006 | CN1760213A Quaterisation chitosan derivatives, preparation method and medicinal preparation containing the derivatives |
| 04/19/2006 | CN1760212A Derivatives of new chitosan, preparation method, and application in use for making ophthalmic preparation |
| 04/19/2006 | CN1760183A New brand of Aripipazole, and preparation method |
| 04/19/2006 | CN1759887A Mucous membrane absorption ingestion type medicinal composition for drawing out interferon, and preparation |
| 04/19/2006 | CN1759880A Prescription of drop pills for treating thrombus and invigorating pulse-beat, and preparation method |
| 04/19/2006 | CN1759861A Recipe of drop pills of compound selfheal spike, and preparation method |
| 04/19/2006 | CN1759858A Prescription of compound unique oil drop pills and preparation method |
| 04/19/2006 | CN1759857A Soft capsule of compound peony and stillbene and production technique |
| 04/19/2006 | CN1759851A Preparation for enriching calcium, and preparation method |
| 04/19/2006 | CN1759844A Enteric coated preparation of Clarithromycin |
| 04/19/2006 | CN1759843A Application of astragaloside in preparing medication for treating peripheral nervous lesion of diabetes |
| 04/19/2006 | CN1759842A Clathrate of Breviscapine, medication composition of containng clathrate of Breviscapine, and preparation method |
| 04/19/2006 | CN1759841A Preparation of bio-membrane in use for promoting wound healing, and preparation method |
| 04/19/2006 | CN1759840A Prescription of oxendolone drop pills and preparation method |
| 04/19/2006 | CN1759839A Recipe of |
| 04/19/2006 | CN1759838A Sildenafil drop pills of adjustable rate of releasing drug |
| 04/19/2006 | CN1759837A Slow release tablet of medetofazone |
| 04/19/2006 | CN1759836A Sublingual tablet of keeping in mouth of Donepezil and derivatives |
| 04/19/2006 | CN1759835A Dextrose translusion of fibrauretime, and preparation method |
| 04/19/2006 | CN1759834A Application of berberine or associated with Simvastatin in preparing product for preventing or curing disease or symptom related to blood fat |
| 04/19/2006 | CN1759833A Application of indole-2,3-diketone in preparing medication for antivirus or immunopotenfiator |
| 04/19/2006 | CN1759832A Carbazochrome sodium sulfonate for injection, and preparation method |
| 04/19/2006 | CN1759831A Application of phenchlobenpyrrone |
| 04/19/2006 | CN1759830A Enteric coated table of duloxetine, and preparation method |
| 04/19/2006 | CN1759829A Duloxetine enteric coated tiny pill capsule, and preparation method |
| 04/19/2006 | CN1759828A Fat emulsion of biobalide B and preparation method |
| 04/19/2006 | CN1759827A Recipe of drop pills of diisopropylamine dichloroacetate, and preparation method |
| 04/19/2006 | CN1759826A Coating method for microcapsule of lysine hydrochloride |
| 04/19/2006 | CN1252241C Health wine for strengthening immunity and its preparing method |
| 04/19/2006 | CN1252130C Hydrophilic polymer and tanshinones medicine conjugation agent and medicine composition containing same |
| 04/19/2006 | CN1252085C Peptide as VEGF receptor KDR antagonist |
| 04/19/2006 | CN1252080C Methods utilizing aryl thioimines in synthesis of erythromycin derivatives |
| 04/19/2006 | CN1252079C Novel substance having physiological activity, process for producing the same, and use |
| 04/19/2006 | CN1252078C Method for extracting total aglycone of Macrotys and its antitumour action |
| 04/19/2006 | CN1252075C Complex ML(DCA) of copper(óÄ), gallium(ó¾) and rare earth ion(Ln**) containing non-methyl canthridic acid radical |
| 04/19/2006 | CN1252074C Compound, its preparation method and its application |
| 04/19/2006 | CN1252071C Xanthine Phosphodiesterase V inhibitors |
| 04/19/2006 | CN1252070C Urea substituted imidazoquinolines |
| 04/19/2006 | CN1252069C 2-aryl-naphthyridin-4-ones as antitumor agent |
| 04/19/2006 | CN1252068C Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1 |
| 04/19/2006 | CN1252067C Benzazole derivatives and their use as JNK modulators |